Targeted analysis of seven selected tryptophan-melatonin metabolites: Simultaneous quantification of plasma analytes …, 2025, Kaleta+

Discussion in 'Other health news and research' started by SNT Gatchaman, Apr 2, 2025 at 7:18 AM.

  1. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,537
    Location:
    Aotearoa New Zealand
    Targeted analysis of seven selected tryptophan-melatonin metabolites: Simultaneous quantification of plasma analytes using fast and sensitive UHPLC–MS/MS
    Kaleta; Kolitha; Novák; Rad; Bergquist; Ubhayasekera

    Tryptophan-derived metabolites, a group of neurotransmitters essential for various brain functions, play key roles in regulating mood, movement, sleep, and cognition. However, the comprehensive characterisation of tryptophan-melatonin pathway metabolites is challenging due to factors such as their structural diversity, chemical complexity, low concentrations, and instability of these metabolites.

    In this study, we developed and validated an ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC–MS/MS) methodology with electrospray ionisation for the simultaneous separation and quantification of tryptophan metabolites in human plasma.

    The analytical calibration ranges in plasma were 0.50–200 ng/mL for serotonin, 0.01–5 ng/mL for N-acetylserotonin, 0.01–20 ng/mL for tryptamine, 0.01–20 ng/mL for 6-sulfatoxymelatonin, 0.01–20 ng/mL for 6-hydroxymelatonin, 0.01–100 ng/mL for melatonin, and 0.10–20 ng/mL for N-acetyltryptamine, with correlation coefficients ranging from 0.954 for N-acetyltryptamine to 0.997 for tryptamine. The intraday and interday precision remained consistently below 15 % for all analytes. Most analytes met the accuracy criteria, except for N-acetyltryptamine at the lowest quality control level (0.2 ng/mL), where the intraday and interday accuracy were 22.4 % and 17.4 %, respectively.

    In conclusion, this novel method allows for rapid identification of tryptophan-melatonin pathway intermediates in less than ten minutes, including seven distinct melatonin-related analytes. This suggests that it may find use in everyday clinical and scientific endeavours.

    Link (Journal of Chromatography B) [Open Access]
     
  2. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,537
    Location:
    Aotearoa New Zealand
  3. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    1,697
    Location:
    Norway
    Thank you! I came across it in SoMe, OMF has written about it:
    https://www.omf.ngo/tryptophan-melatonin-metabolites/

    We’re pleased to share a new publication by Jonas Bergquist, MD, PhD, and colleagues: Targeted analysis of seven selected tryptophan-melatonin metabolites: Simultaneous quantification of plasma analytes using fast and sensitive UHPLC-MS/MS.

    The Heart of the Matter
    • The ME/CFS Collaborative Center at Uppsala published a paper on their new methodology: ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS).
    • This methodology can separate and quantify tryptophan metabolites with good precision and in under ten minutes.
    • Tryptophan metabolites may play a role in two hallmark symptoms of ME/CFS, sleep disturbance and brain fog, indicating UHPLC-MS/MS could be a particularly useful tool in future research into the disease.
     
    Peter Trewhitt, Mij, Anna H and 4 others like this.

Share This Page